What is it? Why is it important?

The Swiss Biobanking Platform (SBP) is a national coordination platform, handling human and non-human Biological Material (BM). As an independent association, initiated by the Swiss National Foundation (SNF) in 2016, SBP responds to the increasing needs of researchers in biomedical science.


SPB’s aims are to:

  • Create a national network of Swiss biobanks, thereby increasing transparency, interconnectedness, and the collaboration between biobanks (SBP NExT)
  • Facilitate the access and optimal usage of high-quality BM (SBP BIMS) (e.g. based on FAIR principles = findable, accessible, interoperable and reusable (BBMRI-ERIC)
  • Promote standards for good biobanking practices, including the documentation of biobanking processes (SBP Labels)


SBP is the Swiss Node of BBMRI-ERIC, and therefore a key intermediate between Swiss biobanks and the European network.

What do I need to do?

Take the opportunity to visit the SBP website and learn more about its proposed services (e.g. quality, visibility, interoperability).


Sign up for the SBP newsletter to receive information on:

  • New releases regarding supporting documents, services and biobanking tools
  • The current biobanking network and its members
  • Planed and upcoming biobanking events

Where can I get help?

Your local CTU can support you with experienced staff regarding this topic

The Swiss Biobanking Platform (SBP) can provide you with support on this topic - see in particular:

  • SBP NExT: Visibility with a national network of Swiss biobanks
  • SBP Labels: Quality with biobanking best practice standards
  • SBP BIMS: Interoperability to promote exchange and use of BM

External Links

PMID : 29359962

  • P. Holub et al, Enhancing Reuse of Data and Biological Material in Medical Research: From FAIR to FAIR-Health


SNF - Swiss National Foundation

  • BIMS – Biobank Information Management System
  • BM – Biological Material
  • BBMRI-ERIC – Biobanking and Biomolecular Resources Research – European Research Infrastructure Consortium
  • CTU – Clinical Trials Unit
  • FAIR – Findability, Accessibility, Interoperability, Reusability
  • PMID – PubMed ID
  • SBP – Swiss Biobanking Platform
  • SNSF – Swiss National Science Foundation
Basic ↦ Biobanking ↦ Swiss Biobanking Platform ↦ Aim

Provides some background knowledge and basic definitions

Basic Monitoring
Basic Drug or Device

Starts with a study idea

Ends after having assessed and evaluated study feasibility

Concept Drug or Device

Starts with confidence that the study is feasible

Ends after having received ethics and regulatory approval

Development Drug or Device

Starts with ethics and regulatory approval

Ends after successful study initiation

Set-Up Ethics and Laws
Set-Up Quality and Risk
Set-Up Drug or Device

Starts with participant recruitment

Ends after the last participant has completed the last study visit

Conduct Drug or Device

Starts with last study visit completed

Ends after study publication and archiving

Completion Statistics
Completion Drug or Device
Current Path (click to copy): Basic ↦ Biobanking ↦ Swiss Biobanking Platform ↦ Aim

Please note: the Easy-GCS tool is currently under construction.